These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11896464)

  • 1. Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv.
    Arafat WO; Gómez-Navarro J; Buchsbaum DJ; Xiang J; Wang M; Casado E; Barker SD; Mahasreshti PJ; Haisma HJ; Barnes MN; Siegal GP; Alvarez RD; Hemminki A; Nettelbeck DM; Curiel DT
    Gene Ther; 2002 Feb; 9(4):256-62. PubMed ID: 11896464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells.
    Li X; Stuckert P; Bosch I; Marks JD; Marasco WA
    Cancer Gene Ther; 2001 Aug; 8(8):555-65. PubMed ID: 11571533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral-mediated delivery of gastrin-releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo.
    Rosenfeld ME; Rogers BE; Khazaeli MB; Mikheeva G; Raben D; Mayo MS; Curiel DT; Buchsbaum DJ
    Clin Cancer Res; 1997 Jul; 3(7):1187-94. PubMed ID: 9815798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted tumor killing via an intracellular antibody against erbB-2.
    Deshane J; Siegal GP; Alvarez RD; Wang MH; Feng M; Cabrera G; Liu T; Kay M; Curiel DT
    J Clin Invest; 1995 Dec; 96(6):2980-9. PubMed ID: 8675670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.
    Afanasieva TA; Wittmer M; Vitaliti A; Ajmo M; Neri D; Klemenz R
    Gene Ther; 2003 Oct; 10(21):1850-9. PubMed ID: 12960975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
    Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
    Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
    Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon optimization, expression, and characterization of an internalizing anti-ErbB2 single-chain antibody in Pichia pastoris.
    Hu S; Li L; Qiao J; Guo Y; Cheng L; Liu J
    Protein Expr Purif; 2006 May; 47(1):249-57. PubMed ID: 16403645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target.
    Arafat W; Gómez-Navarro J; Xiang J; Siegal GP; Alvarez RD; Curiel DT
    Cancer Gene Ther; 2000 Sep; 7(9):1250-6. PubMed ID: 11023197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery.
    Hedley SJ; Auf der Maur A; Hohn S; Escher D; Barberis A; Glasgow JN; Douglas JT; Korokhov N; Curiel DT
    Gene Ther; 2006 Jan; 13(1):88-94. PubMed ID: 16107860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins.
    Whittington HA; Ashworth LJ; Hawkins RE
    Gene Ther; 1998 Jun; 5(6):770-7. PubMed ID: 9747457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and Characterization of Single-chain Fv-Fc Fusion Protein against Human P185(erbB2)].
    Xie ZG; Guo N; Shi M; Feng JN; Yu M; Sun YX; Shen BF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):371-4. PubMed ID: 12673393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
    Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
    Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.
    Deshane J; Siegal GP; Wang M; Wright M; Bucy RP; Alvarez RD; Curiel DT
    Gynecol Oncol; 1997 Mar; 64(3):378-85. PubMed ID: 9062138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient growth inhibition of ErbB2-overexpressing tumor cells by anti-ErbB2 ScFv-Fc-IL-2 fusion protein in vitro and in vivo.
    Shi M; Zhang L; Gu HT; Jiang FQ; Qian L; Yu M; Chen GJ; Luo Q; Shen BF; Guo N
    Acta Pharmacol Sin; 2007 Oct; 28(10):1611-20. PubMed ID: 17883948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
    Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
    Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
    Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
    Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.